PMID: 35658024): The study showed mean weight reduction of 15.0% , 19.5% , 20.9% vs 3.1% placebo at 72 weeks The study showed up to 36% of participants achieved 25% or more weight loss with tirzepatide 15 mg Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes (SURMOUNT-2) , published in The Lancet (Garvey WT et al., 2023
Creating lasting changes means letting go of perfection and embracing what's realistic, flexible andwhat do you knowfeels GOOD
The peptide blend offers a new way to study whether dual-pathway activation changes markers of adiposity, fatty acid oxidation, or body composition
(Utilization in the commercial and Medicaid businesses were as expected.) Lower-than-expected MA reimbursement: Optum Health, United's care delivery division that serves Medicare patients (mostly UHC MA enrollees), grew as patients moved from market-exiting plans to plans (like UHC) that contracted with Optum provider services
Compounded semaglutide is not the same medication as Wegovy
Both drugs are being developed by Novo Nordisk, likely reflecting a portfolio strategy: CagriSema as the first-to-market injectable combination, and amycretin as a follow-on oral option for patients who prefer pills
